Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 49701-49750 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT04433351
Sensory-Motor Integration for Speech Rehabilitation in Patients with Post-stroke Aphasia
NARecruiting
36 participants
Started: May 5, 2022 · Completed: Mar 31, 2026
2 conditions3 sponsors1 location
NCT05385926
Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
PHASE2Recruiting
34 participants
Started: May 5, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT05548712
The Effect of PEMF for Patients With Knee OA
NARecruiting
80 participants
Started: May 5, 2022 · Completed: Sep 15, 2024
2 conditions1 sponsor1 location
NCT05741814
Propofol Sedation vs. Anaesthetist Guided Anaesthesia in Oocyte Pickup
NARecruiting
100 participants
Started: May 5, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04644289
WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC
PHASE2Recruiting
60 participants
Started: May 5, 2022 · Completed: Jun 30, 2028
1 condition1 sponsor6 locations
NCT05040360
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
PHASE2Recruiting
141 participants
Started: May 5, 2022 · Completed: Mar 31, 2027
5 conditions2 sponsors319 locations
NCT04732416
HM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
PHASE2Recruiting
16 participants
Started: May 5, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor7 locations
NCT05225363
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer
PHASE1Recruiting
33 participants
Started: May 5, 2022 · Completed: Jun 5, 2027
1 condition2 sponsors1 location
NCT05395325
Clinical Effects of Combined Kinesiotaping and Steroid Injection in Stroke Patients With Hemiplegic Shoulder Pain
NARecruiting
50 participants
Started: May 5, 2022 · Completed: Aug 31, 2024
2 conditions1 sponsor1 location
NCT05416879
Lifestyle Behaviours of Women Newly Diagnosed With Heart Failure
N/ARecruiting
40 participants
Started: May 5, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05371626
Cicatricial Upper Eyelid Entropion Management
NARecruiting
30 participants
Started: May 5, 2022 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT04976036
Efficacy of Nintedanib for Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) Patients
PHASE2Recruiting
48 participants
Started: May 5, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05550246
Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy
PHASE1/PHASE2Recruiting
22 participants
Started: May 5, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05267041
Joint Thoracic Oncology Research Unit of LYon: Lung CancerS DatabaSE (ULYSSE)
NARecruiting
4,000 participants
Started: May 5, 2022 · Completed: May 5, 2042
1 condition1 sponsor1 location
NCT05221359
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
NARecruiting
8 participants
Started: May 5, 2022 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT05090891
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
PHASE2Recruiting
98 participants
Started: May 5, 2022 · Completed: Dec 23, 2032
1 condition1 sponsor27 locations
NCT05151120
Harmonization of Thyroid-stimulating Hormone Immunoassays Reagents
N/ARecruiting
100 participants
Started: May 5, 2022 · Completed: May 5, 2026
2 conditions1 sponsor2 locations
NCT05078164
Preventing Firearm Violence in Youth: A Hospital-based Prevention Strategy
NARecruiting
300 participants
Started: May 4, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05973981
The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment
NARecruiting
900 participants
Started: May 4, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05140434
Evaluation of the Benefit of Exercise Testing for the Diagnosis of Obstruction in the Coronary Arteries of the Heart
N/ARecruiting
120 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06128148
Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors
PHASE1Recruiting
101 participants
Started: May 4, 2022 · Completed: Dec 30, 2027
4 conditions1 sponsor1 location
NCT05807256
Medically Assisted Fertilization Techniques in Systemic Immunoreumatologic Diseases
N/ARecruiting
500 participants
Started: May 4, 2022 · Completed: Nov 30, 2025
5 conditions1 sponsor1 location
NCT05347771
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
PHASE2Recruiting
240 participants
Started: May 4, 2022 · Completed: Dec 15, 2025
1 condition4 sponsors8 locations
NCT05371964
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis
PHASE1Recruiting
51 participants
Started: May 4, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor8 locations
NCT05365672
Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
PHASE2Recruiting
126 participants
Started: May 4, 2022 · Completed: Dec 31, 2028
1 condition2 sponsors8 locations
NCT05085171
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
PHASE3Recruiting
2,400 participants
Started: May 4, 2022 · Completed: Sep 1, 2027
1 condition2 sponsors1 location
NCT05344703
Is Y-Balance Test Predictive of Concussion
NARecruiting
1,000 participants
Started: May 4, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor2 locations
NCT05179876
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other Option
PHASE3Recruiting
280 participants
Started: May 4, 2022 · Completed: Sep 28, 2029
1 condition1 sponsor40 locations
NCT05356182
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
NARecruiting
30 participants
Started: May 4, 2022 · Completed: Feb 28, 2027
3 conditions1 sponsor1 location
NCT05514028
Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin
N/ARecruiting
250 participants
Started: May 4, 2022 · Completed: Apr 30, 2026
3 conditions3 sponsors12 locations
NCT05285566
Pain Control for Undergoing Costal Cartilage Harvesting
PHASE4Recruiting
60 participants
Started: May 4, 2022 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT05183490
R-MVST Cells for Treatment of Viral Infections
PHASE1Recruiting
36 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05398276
Behavioral Exposure for Introceptive Tolerance RCT
PHASE2Recruiting
146 participants
Started: May 3, 2022 · Completed: Jul 31, 2026
4 conditions2 sponsors2 locations
NCT05159856
Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes
N/ARecruiting
400 participants
Started: May 3, 2022 · Completed: Dec 31, 2025
5 conditions2 sponsors1 location
NCT05380713
......SMARTEST Trial......
PHASE2Recruiting
30 participants
Started: May 3, 2022 · Completed: Oct 30, 2028
1 condition2 sponsors1 location
NCT05296746
Neoadjuvant and Adjuvant Ribociclib and ET for Clinically High-risk ER+ and HER2- Breast Cancer
PHASE2Recruiting
1,100 participants
Started: May 3, 2022 · Completed: Dec 1, 2031
1 condition3 sponsors51 locations
NCT05085704
Brain Metabolism Observed at 7 Tesla
N/ARecruiting
20 participants
Started: May 3, 2022 · Completed: Sep 20, 2026
7 conditions1 sponsor1 location
NCT04918186
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer
PHASE2Recruiting
60 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors7 locations
NCT04879329
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
PHASE2Recruiting
372 participants
Started: May 3, 2022 · Completed: Apr 14, 2029
1 condition2 sponsors183 locations
NCT05351424
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
NARecruiting
194 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT05366881
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
N/ARecruiting
7,000 participants
Started: May 3, 2022 · Completed: Dec 31, 2026
20 conditions1 sponsor15 locations
NCT05356195
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Transfusion-Dependent β-Thalassemia (TDT)
PHASE3Recruiting
15 participants
Started: May 3, 2022 · Completed: May 31, 2026
5 conditions2 sponsors6 locations
NCT04657861
APRIL CAR-T Cell Therapy for Patients With BCMA/TACI Positive Relapsed and/or Refractory Multiple Myeloma
EARLY_PHASE1Recruiting
36 participants
Started: May 3, 2022 · Completed: Aug 20, 2027
2 conditions2 sponsors1 location
NCT05369052
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
PHASE3Recruiting
865 participants
Started: May 3, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor14 locations
NCT05533528
Periodontal Granulation Tissue Preservation in Surgical Periodontitis Treatment
NARecruiting
25 participants
Started: May 3, 2022 · Completed: Feb 1, 2026
3 conditions1 sponsor1 location
NCT05296681
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery
PHASE2Recruiting
42 participants
Started: May 3, 2022 · Completed: Jul 1, 2025
5 conditions1 sponsor10 locations
NCT05197881
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
NARecruiting
125 participants
Started: May 3, 2022 · Completed: Sep 30, 2030
1 condition1 sponsor5 locations
NCT05357638
Physical Training for People With Parkinson's Disease and Multiple Sclerosis: Effect on Mind and Body
NARecruiting
48 participants
Started: May 2, 2022 · Completed: Nov 2, 2025
2 conditions2 sponsors1 location
NCT05406856
PROTECT: On-line Adaptive Proton Therapy for Cervical Cancer
NARecruiting
30 participants
Started: May 2, 2022 · Completed: Dec 1, 2026
2 conditions3 sponsors2 locations
NCT05255302
De-escalation Immunotherapy mAintenance Duration Trial for Stage IV Lung Cancer Patients With Disease Control After Chemo-immunotherapy Induction
PHASE2/PHASE3Recruiting
1,360 participants
Started: May 2, 2022 · Completed: Jun 1, 2029
1 condition1 sponsor44 locations